BG Medicine Named To Russell 3000 Investment Index
WALTHAM, Mass., (GLOBE NEWSWIRE) - BG Medicine, Inc. (Nasdaq:BGMD) today announced that it has been added to the Russell 3000® Index, which measures the performance of the 3,000 largest publicly-traded U.S. companies based on total market capitalization. The Russell 3000 Index is constructed to provide a comprehensive barometer of the broad market and is reconstituted annually to capture new and growing companies.
"Following our initial public offering on February 4, 2011, we are very pleased to be added to the Russell 3000 Index,"
said Pieter Muntendam, M.D., president and chief executive officer of BG Medicine.
"Our inclusion in this index provides additional visibility for BG Medicine in the investment community as many investors rely on the Russell indices as part of their investment strategy."
About BG Medicine
BG Medicine is a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs. BG Medicine recently launched the galectin-3 test for use in patients with heart failure. The galectin-3 test is the first novel blood test for cardiac disease cleared by the FDA in five years. For additional information about BG Medicine and galectin-3 testing, please visit www.bg-medicine.com and www.galectin-3.com.
About Gilde Healthcare Partners
Netherlands-based Gilde Healthcare Partners (www.gildehealthcare.nl) is a transatlantic venture and growth capital firm focused on private healthcare technologies and services. It has over €400 million under management and is actively looking to lead new investments in therapeutics, diagnostics, medical devices and services. Gilde successfully builds healthcare businesses across Europe and US, investing up to €15 million in a single portfolio company. By investing in companies with clear achievable business models, Gilde has used its financial resources and network to create significant value for both its investors and the entrepreneurs it backs. For a list of Gilde’s portfolio companies please visit the website.